Make an Enquiry:-
https://www.infiniumglobalresearch.com/Reports/MakeEnquiryRequest/17
Segments Covered:
The report segments the global biosimilar market by product, application and region. On the basis of product,
the market is segmented as human growth hormones, monoclonal antibodies, insulin, peptides,
erythropoietin and others. Based on application, the market is segmented as oncology, chronic and
autoimmune diseases, growth hormone deficiency, infectious diseases and others.
Geographic Coverage and Analysis:
The report provides regional analysis covering geographies such as North America, Europe, Asia-Pacific, and
Rest of the World. With the maximum number of approved biosimilars, European market is the major
biosimilar market in the world. Countries such as France, Germany, Italy and United Kingdom drive the
growth of the European biosimilar market with high demand for low cost alternatives for biologics medicines.
Expiry of patents for certain biologics medicines and presence of good regulatory frameworks set up by
European Medical Association are expected to aid the growth of the European biosimilar market, during the
forecast period. Asia-Pacific region has significant biosimilars in use due to the relaxed regulations in various
countries. Due to the presence of large population and need for low cost alternative medicines for various
diseases in countries such as China, India, South Korea and others drive the growth of biosimilar market in
Asia-Pacific. As the rate of approvals for biosimilars are increasing at a faster pace in the U.S., the North-
American region is expected to become the fastest growing biosimilar market during the forecast period. The
pharmaceutical companies in the North American region are expected to make use of the research and
development initiatives related to biosimilars and expiring biologics patents for increasing the production of
Infinium Global Research